Multicomponent Degradable Cationic Polymers for Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene delivery methods face challenges in achieving safe and effective delivery of genetic material, particularly due to cytotoxicity issues with polyethylenimine (PEI) and lower effectiveness compared to viral methods.
Innovation Solution
The development of multicomponent degradable cationic polymers, such as poly (beta-amino ester)s and bioreducible polymers, which are designed to bind DNA, facilitate cellular uptake, escape endosomes, and release genetic material in the cytoplasm, while minimizing cytotoxicity through biodegradable linkages.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If polyethylenimine (PEI) is used for gene delivery, then gene delivery efficacy is improved, but cytotoxicity increases significantly
Solution Approach 1:
The patent divides the polymer structure into multiple components: a biodegradable backbone (poly(beta-amino ester)) and cationic functional groups for DNA binding. This segmentation allows the polymer to achieve effective gene delivery through cationic interactions while the biodegradable backbone reduces cytotoxicity by breaking down into non-toxic products
Solution Approach 2:
The patent modifies the chemical structure parameters of the polymer by incorporating biodegradable ester linkages and adjusting the cationic charge density. These parameter changes enable the polymer to maintain sufficient positive charge for DNA binding and cellular uptake while allowing controlled degradation to reduce cytotoxicity
2Productivity
If viral gene delivery methods are used, then gene delivery effectiveness is improved, but safety concerns increase
Solution Approach 1:
The patent uses synthetic cationic polymers as an intermediary between viral vectors and non-viral methods. These polymers mimic the effective DNA binding and cellular uptake mechanisms of viral vectors while eliminating the safety risks associated with viral integration and immune responses
Solution Approach 2:
The patent employs biodegradable polymers that are designed to be temporary and self-limiting. These polymers perform their gene delivery function and then degrade into non-toxic products, unlike viral vectors that can persist and cause long-term safety issues
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These polymers demonstrate enhanced gene delivery efficacy, reduced cytotoxicity, and the ability to rival adenovirus delivery in vitro and in vivo, making them suitable for therapeutic applications, including cancer treatment and regenerative medicine.
Implementation Method 1
Many biomaterials, including cationic lipids, sugars, peptides, and polymers, have been shown to be effective for delivering genes in vitro... poly (beta-amino ester)s are readily biodegradable due to their ester linkages
Implementation Method 2
PEI, which, due its cationic structure, can be very effective for binding DNA and forming gene delivery particles
Implementation Method 3
PEI also is particularly effective at promoting endosomal escape of PEI/DNA particles through the proton sponge mechanism. This mechanism is critical in preventing lysosomal degradation of the DNA
Data Source
AI summary
Degradable polymers were synthesized that self-assemble with DNA to form particles that are effective for gene delivery. Small changes to polymer synthesis conditions, particle formulation conditions, and polymer structure provides significant changes to efficacy in a cell-type dependent manner. Polymers presented here are more effective than commercially available materials, such as LIPOFECTAMINE 2000™, FUGENE®, or polyethylenimine (PEI), for gene delivery to cancerous fibroblasts or human primary fibroblasts. The presently disclosed materials may be useful for cancer therapeutics and regenerative medicine.